Trial Profile
An Open Clinical Trial to Evaluate GanovoDanoprevir Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2020
Price :
$35
*
At a glance
- Drugs Danoprevir (Primary) ; Ritonavir (Primary) ; Interferon alpha
- Indications COVID-19 pneumonia; SARS-CoV-2 acute respiratory disease
- Focus Adverse reactions
- 25 Nov 2020 Results evaluating the safety and efficacy of of danoprevir boosted by ritonavir on treatment naive and experienced COVID-19 patients, published in the Medicine
- 24 Mar 2020 According to an Ascletis media release, data from this small-sample clinical study was published in medRxiv.
- 24 Mar 2020 Results presented in an Ascletis media release.